Results 21 to 30 of about 309,486 (306)
Hepatology, EarlyView., 2022 NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger +7 more
wiley +1 more source
Additional file 1 of The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA
, 2023 Additional file 1. ARRIVE Guideline.
Cheng, Rui +9 more
openaire +1 more source
Effect of atorvastatin on hs‐CRP in acute coronary syndrome [PDF]
British Journal of Clinical Pharmacology, 2008 WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Markers of inflammation are being investigated as predictors of coronary ischaemic events. All major statins have shown almost similar and significant efficacy in reducing C‐reactive protein (CRP) concentrations in acute coronary syndrome (ACS), but atorvastatin was used in a high dose (80 mg).• This study ...
Ankur, Gupta +5 more
openaire +2 more sources
Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis [PDF]
Open Medicine, 2018 Abstract Objective Elevation of serum high sensitivity C-reactive protein (hs-CRP) level has been demonstrated as a risk factor for varying diseases, as well as a biomarker for predicting recovery after operation of lumber disc herniation.
Liu Te-Jung +5 more
openaire +3 more sources
Journal of Primary Care & Community Health, 2020 Introduction The correlation between inflammation and vascular disease is widely accepted. High levels of C-reactive protein (CRP) have been shown to play a role in the process of endothelial dysfunction.
Sharmila Bisaria +3 more
doaj +1 more source
National Journal of Physiology, Pharmacy and Pharmacology, 2023 Background: The incidence and prevalence of hypertension have been increasing steadily in the present era. Inflammation is a proven key factor in the pathogenesis of hypertension.
Hemalatha P, Prince Johnson Samuel
doaj +1 more source
A Potential Combination Of HDL-Cholesterol And Hs-CRP For Inflammation Monitoring In CKD Patient With Statin Therapy [PDF]
, 2020 Reducing inflammation can be one of the therapeutic targets in in Chronic Kidney Disease (CKD) patients. Many studies have shown that statins have pleiotropic effects as anti-inflammation.
Mochammad Thaha, - +3 more
core +1 more source
Evaluation of HS-CRP and Lipid Profile in COPD
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013 COPD is a major public health problem. More than 50 % of the patients of COPD die because of some cardiovascular event. Traditionally, the risk of CVD is assessed by the presence of dyslipidaemia. Recently, HS-CRP has emerged as a novel risk factor for the CVD assessment.
Anup N. Nillawar +4 more
openaire +3 more sources
Cardiovascular Diabetology, 2020 Background High-sensitivity C-reactive protein (hs-CRP) elevation frequently occurs in acute myocardial infarction (AMI) and is associated with adverse outcomes.
Claudia Lucci +16 more
doaj +1 more source
Relationship between hs-CRP and cardiac efficiency in chronic alcoholics [PDF]
Indian Journal of Clinical Biochemistry, 2008 High sensitive C-reactive protein (hs-CRP), a non-specific marker of inflammatory status has considerable interest focused due to its ability to predict myocardial infarction, stroke, peripheral arterial disease and sudden cardiac death. Alcoholics are known to be associated with inflammation of heart. This study was taken up to look for an association
R, Latha, K, Chandrakala Shenoy
openaire +2 more sources